Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

NCT06674265 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuroblastoma, Recurrent, Refractory
Neuroblastoma (NB)
Neuroblastoma in Children

Interventions

BIOLOGICAL: Allogenic NK cells infusion

Sponsor

Marzieh Ebrahimi

Collaborators

[object Object]
[object Object]